ALLGENESIS BIOTHERAPEUTICS INC.

Organization

TAIPEI CITY, TW

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Fusion proteins for inhibiting angiogenesis
- Patent number 12,152,057
- Issue date Nov 26, 2024
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGFR fusion protein pharmaceutical composition
- Patent number 11,723,955
- Issue date Aug 15, 2023
- Allgenesis Biotherapeutics Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...
- Patent number 11,369,600
- Issue date Jun 28, 2022
- Allgenesis Biotherapeutics Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion protein comprising a ligand binding domain of VEGF and PDGF
- Patent number 11,299,531
- Issue date Apr 12, 2022
- Allgenesis Biotherapeutics Inc.
- Kevin Zen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins for inhibiting angiogenesis
- Patent number 11,192,927
- Issue date Dec 7, 2021
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methyl...
- Patent number 10,961,203
- Issue date Mar 30, 2021
- Allgenesis Biotherapeutics Inc.
- Fei Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and their use as BACE1 inhibitors
- Patent number 10,870,635
- Issue date Dec 22, 2020
- Allgenesis Biotherapeutics, Inc.
- Madhu Cherukury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...
- Patent number 10,154,994
- Issue date Dec 18, 2018
- Allgenesis Biotherapeutics, Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20240408083
- Publication date Dec 12, 2024
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN AGONIST OF FORMYL PEPTIDE RECEPTORS 1 AND 2 FOR TREATING...
- Publication number 20240374753
- Publication date Nov 14, 2024
- Allgenesis Biotherapeutics Inc.
- Ching-Yu LAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGFR Fusion Protein Pharmaceutical Composition
- Publication number 20230364185
- Publication date Nov 16, 2023
- Allgenesis Biotherapeutics Inc.
- Tan Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20220280506
- Publication date Sep 8, 2022
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
- Publication number 20200181214
- Publication date Jun 11, 2020
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF 3-Z-[1-(4-(N-((4-METHYL-PIPERAZIN-1-YL)-METHYL...
- Publication number 20200002294
- Publication date Jan 2, 2020
- Allgenesis Biotherapeutics Inc.
- Fei LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
- Publication number 20190194271
- Publication date Jun 27, 2019
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20180243294
- Publication date Aug 30, 2018
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND THEIR USE AS BACE1 INHIBITORS
- Publication number 20180201604
- Publication date Jul 19, 2018
- ALLGENESIS BIOTHERAPEUTICS, INC.
- Madhu CHERUKURY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR INHIBITING ANGIOGENESIS
- Publication number 20180170979
- Publication date Jun 21, 2018
- Allgenesis Biotherapeutics Inc.
- Pei-Tzu WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN COMPRISING A LIGAND BINDING DOMAIN OF VEGF AND PDGF
- Publication number 20170369552
- Publication date Dec 28, 2017
- Allgenesis Biotherapeutics Inc.
- Kevin ZEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...
- Publication number 20170368061
- Publication date Dec 28, 2017
- Allgenesis Biotherapeutics Inc.
- Tan NGUYEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
87741560 - ALLGENESIS
- Serial number 87741560
- Registration number 5707152
- Filing date Jan 3, 2018
- Allgenesis Biotherapeutics Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86569569 - ALLGENESIS BIOTHERAPEUTICS
- Serial number 86569569
- Registration number 4953911
- Filing date Mar 19, 2015
- ALLGENESIS BIOTHERAPEUTICS INC.
- 42 - Scientific and technological services and research and design relating thereto

ALLGENESIS BIOTHERAPEUTICS INC.

Organization

Patents Grantslast 30 patents

Fusion proteins for inhibiting angiogenesis

VEGFR fusion protein pharmaceutical composition

Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...

Fusion protein comprising a ligand binding domain of VEGF and PDGF

Fusion proteins for inhibiting angiogenesis

Crystalline forms of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methyl...

Compounds and their use as BACE1 inhibitors

Ophthalmic formulations of tyrosine kinase inhibitors, methods of u...

Patents Applicationslast 30 patents

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

USE OF AN AGONIST OF FORMYL PEPTIDE RECEPTORS 1 AND 2 FOR TREATING...

VEGFR Fusion Protein Pharmaceutical Composition

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

FUSION PROTEINS FOR INHIBITING ANGIOGENESIS

CRYSTALLINE FORMS OF 3-Z-[1-(4-(N-((4-METHYL-PIPERAZIN-1-YL)-METHYL...

FUSION PROTEINS FOR INHIBITING ANGIOGENESIS

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

COMPOUNDS AND THEIR USE AS BACE1 INHIBITORS

FUSION PROTEINS FOR INHIBITING ANGIOGENESIS

FUSION PROTEIN COMPRISING A LIGAND BINDING DOMAIN OF VEGF AND PDGF

OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF U...

Trademarklast 30 trademarks

87741560 - ALLGENESIS

86569569 - ALLGENESIS BIOTHERAPEUTICS